Clinical Trials on Benign Prostatic Hypertrophy (BPH)

Total 482 results

Boston Scientific Corporation

Completed

To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China

Benign Prostatic Hyperplasia (BPH)

China
Samsung Medical Center

Completed

Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
PROCEPT BioRobotics

Completed

French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue

Benign Prostatic Hyperplasia (BPH)

France
University of Bari
Gaetano de Rienzo; Pasquale Ditonno; Francesco Di Modugno; Michele Battaglia; Giuseppe... and other collaborators

Unknown

Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques

Benign Prostatic Hyperplasia (BPH)

Italy
University of Helsinki
University of Turku; Oulu University Hospital; Tampere University; South Ostrobothnia...

Completed

KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate)

BPH (Benign Prostatic Hyperplasia)

Finland
Pierre Fabre Medicament

Completed

PERmixon® in LUTS Evaluation Study (PERLES) (PERLES)

Benign Prostatic Hyperplasia (BPH)

France, Italy, Germany, Spain, Czech Republic
Korea University Anam Hospital
GL Pharm Tech Corporation

Completed

PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
Eli Lilly and Company

Completed

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

Italy, France, Belgium, Australia, Greece, Austria, Netherlands, Germany, Mexico, Poland
National Institute of Diabetes and Digestive and...
George Washington University

Completed

Medical Therapy of Prostatic Symptoms (MTOPS)

Prostatic Hyperplasia | Prostatic Hypertrophy, Benign

United States
Dr. med. Gautier Müllhaupt

Recruiting

Aquablation vs. Holmium Laser Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia in Medium to Large Size Prostates (ATHLETE)

Benign Prostatic Hyperplasia (BPH)

Switzerland
Assiut University

Completed

HoLEP in Management of BPH Patients With Predominant Voiding vs Storage LUTS: A Comparative Retrospective Study

Benign Prostatic Hyperplasia (BPH)

Egypt
Organon and Co

Terminated

A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)

Benign Prostatic Hyperplasia (BPH)
Medi-Tate Ltd.

Terminated

A Multi-center, International Prospective Follow up Study

Benign Prostatic Hyperplasia (BPH)

Canada, United States
NeoTract, Inc.

Completed

Study of Median Lobe Prostatic UroLift Procedure

Benign Prostatic Hyperplasia (BPH)
University of Helsinki

Completed

KTP Green Light Prostatectomy Compared With Open Prostatectomy

BPH (Benign Prostatic Hyperplasia)

Finland
Nymox Corporation

Completed

Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018

Benign Prostatic Hyperplasia (BPH)

United States
Guang'anmen Hospital of China Academy of Chinese...

Completed

An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

China
Pierre Fabre Medicament

Completed

Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) (PERMIN)

Benign Prostatic Hyperplasia (BPH)

France, Spain, Portugal, Italy
ProArc Medical

Completed

Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic Hyperplasia

Benign ProstaticHyperplasia (BPH)

Israel, Latvia
Assistance Publique - Hôpitaux de Paris
Merck Sharp & Dohme LLC

Completed

Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration (ERTAPRO)

Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection

France
Rhode Island Hospital

Terminated

Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hypertrophy

United States
University of Magdeburg

Completed

Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the Prostate (SATURN-P)

Benign Prostatic Hypertrophy

Germany
JW Pharmaceutical

Completed

Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH

Benign Prostatic Hypertrophy

Korea, Republic of
Cedar, United Kingdom
National Institute for Health and Care Excellence (NICE); British Society of... and other collaborators

Unknown

ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE). (UKROPE)

Transurethral Resection of the Prostate (TURP) | Lower Urinary Tract Symptoms Caused by Benign Prostatic Enlargement (LUTS BPE) | Prostate Artery Embolisation (PAE) | Open Prostatectomy | Laser Enucleation or Ablation of the Prostate
Astellas Pharma Inc

Completed

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

Overactive Bladder | Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy

Japan
Siami, Paul F., M.D.
GlaxoSmithKline; Pfizer

Completed

Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) (LUTS)

Benign Prostatic Hyperplasia (BPH)

United States
ClinSearch
Biocompatibles UK Ltd; European Georges Pompidou Hospital

Unknown

Prostate Embolization for Acute Urinary Retention Study (PARIS1)

Prostatic Hypertrophy, Benign

France
Northwestern University

Completed

Wolf 24 F vs. Storz 28 F Laser Sheath Size for HoLEP

Benign Prostatic Hypertrophy

United States
University of Mississippi Medical Center

Recruiting

Prostate Artery Embolization: Single Center Experience

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia (BPH)

United States
Beth Israel Deaconess Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Urinary Obstruction | Prostate Disease | Prostate Hyperplasia | Prostate Hypertrophy | Prostate Pain | Urinary Tract Disease

United States
ThermaRx, Inc.

Completed

A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary Hesitancy

Urinary Retention | Benign Prostatic Hyperplasia (BPH) | Urinary Hesitancy Intermittent

United States
Hospital Universitari Vall d'Hebron Research Institute

Recruiting

Application of MOSES Technology in BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia (BPH)

Spain
Sanofi

Completed

Clinical Trial in Males With BPH (Enlarged Prostate)

Prostatic Hyperplasia | Urinary Retention | Benign Prostatic Hypertrophy

United States, Canada, Poland, Romania, Australia, Netherlands, Portugal, Spain, Sweden, Bulgaria, Denmark, Finland, Hungary, Norway, South Africa, Greece, Israel
Chinese University of Hong Kong

Active, not recruiting

To Linguistically and Psychometrically Validate the Hong Kong Chinese Version of the BPH 3-item Questionnaire

Benign Prostatic Hyperplasia (BPH)

Hong Kong
University Hospital, Basel, Switzerland
Boston Scientific Corporation

Recruiting

SteamOne - Prospective Registry Database for Rezum Water Vapor Therapy of the Prostate (SteamOne)

Benign Prostate Obstruction (BPO)

Switzerland
Spectrum Pharmaceuticals, Inc

Terminated

Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH) | Lower Urinary Tract Symptoms (LUTS)

United States
Samsung Medical Center
GlaxoSmithKline

Completed

Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction

Benign Prostatic Hyperplasia

Korea, Republic of
NorthShore University HealthSystem
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Effects of TNF Blockade on Human BPH/LUTS

Benign Prostatic Hyperplasia (BPH)

United States
University of Helsinki

Active, not recruiting

KTP Green Light Prostatectomy Compared With TUR-P in High Risk Patients

BPH (Benign Prostatic Hyperplasia)

Finland
Northwestern University

Completed

Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH)

United States
Boston Scientific Corporation

Completed

China Greenlight Registry Study (Post-market)

Benign Prostatic Hyperplasia (BPH)

China
PROCEPT BioRobotics

Completed

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER) (WATER)

Benign Prostatic Hyperplasia (BPH)

United States, Australia, United Kingdom, New Zealand
Boston Scientific Corporation

Recruiting

REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men (VAPEUR RCT)

Benign Prostatic Hyperplasia (BPH)

France, Australia
Olympus Corporation of the Americas

Recruiting

A Randomized, International Study to Assess the Safety of iTind Compared to UroLift (MT-08)

Benign Prostatic Hyperplasia (BPH)

United States, United Kingdom, Canada
HistoSonics, Inc.

Terminated

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)

Benign Prostatic Hyperplasia (BPH)

United States
Northwestern University
BTG International Inc.

Completed

Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres

Benign Prostatic Hyperplasia (BPH)

United States
PROCEPT BioRobotics

Completed

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II (WATERII)

Benign Prostatic Hyperplasia (BPH)

United States, Canada
National Cheng-Kung University Hospital
National Cheng Kung University; National Research Program for Biopharmaceuticals... and other collaborators

Unknown

Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia

Lower Urinary Tract Symptom | Benign Prostatic Hyperplasia (BPH)

Taiwan
Astellas Pharma Inc
Astellas Pharma Singapore Pte. Ltd.

Completed

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Overactive Bladder

Japan, Korea, Republic of
Nymox Corporation

Completed

Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)

Benign Prostatic Hyperplasia | BPH | LUTS | Lower Urinary Tract Symptoms (LUTS)

United States

Clinical Trials on Benign Prostatic Hypertrophy (BPH)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations